prazosin has been researched along with Movement Disorders in 1 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shliakhto, EV | 1 |
| Nedogoda, SV | 1 |
| Nifontov, EM | 1 |
| Pushkarev, AA | 1 |
| Savushkin, SN | 1 |
1 other study available for prazosin and Movement Disorders
| Article | Year |
|---|---|
[A case of intolerance to the adrenergic alpha1 blockader prazosin].
Topics: Affective Symptoms; Humans; Hypotension, Orthostatic; Male; Middle Aged; Movement Disorders; Prazosi | 1988 |